Remel Shigella Polyvalent Agglutinating Sera - HSA Registration DE0016001
Access comprehensive regulatory information for Remel Shigella Polyvalent Agglutinating Sera in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0016001 and owned by Remel Europe Limited. The device was registered on July 17, 2014.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Shigella Polyvalent Agglutinating Sera are suitable for use in slide agglutination tests to identify Shigella cultures presumptively for epidemiological and diagnostic purposes. Antisera provide serological identification only; full identification of an organism must be made in conjunction with biochemical testing.

